NDC 63323-642-01 - Magnesium Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-642
- Requested NDC
- 63323-642-01
- Package NDCs from labels
- 63323-642-01, 63323-642-20, 63323-642-02, 63323-642-50
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2025-10-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Magnesium Sulfate | Henry Schein, Inc. | 2025-10-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Magnesium Sulfate | General Injectables and Vaccines, Inc. | 2022-12-27 | HUMAN PRESCRIPTION DRUG LABEL |
| MAGNESIUM SULFATE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2022-12-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Magnesium Sulfate - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2021-12-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-642-01 | Magnesium Sulfate | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 3 | |
| 63323-642-02 | Magnesium Sulfate | 50 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 50 | 3 | |
| 63323-642-20 | Magnesium Sulfate | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 3 | |
| 63323-642-50 | Magnesium Sulfate | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-642-01 | ML - Milliliter | 63323-642 | 578218da-5272-4988-b9c5-832b4ba6b5f5 | 1 | 2022-07-06 |
| 63323-642-02 | ML - Milliliter | 63323-642 | c3217431-9483-41a1-9a90-c1a6cd024cf3 | 1 | 2022-07-06 |
| 63323-642-20 | ML - Milliliter | 63323-642 | fa0d8848-a02a-442c-8c1b-185d23f9d5be | 1 | 2016-06-14 |
| 63323-642-50 | ML - Milliliter | 63323-642 | dba8c816-487e-4e61-99bf-7fc49cdf02bf | 1 | 2016-06-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Magnesium Sulfate | MAGNESIUM SULFATE HEPTAHYDRATE | Fresenius Kabi USA, LLC | 77f70e00-3934-4fd9-a581-4cf3df8c42d2 | 2021-12-13 | Warnings, Adverse reactions | NDA019316 63323-642-20 63323-642-02 63323-642-50 63323-642-01 63323-642 63323064201 1658245 1658236 89d02988-a12e-4224-88f0-3f05f7ee324f 77f70e00-3934-4fd9-a581-4cf3df8c42d2 SK47B8698T |
| Magnesium Sulfate | MAGNESIUM SULFATE HEPTAHYDRATE | Medical Purchasing Solutions, LLC | b6352fbd-d3ee-2d3a-e053-2a95a90a747d | 2020-12-11 | Warnings, Adverse reactions | NDA019316 SK47B8698T |
| Magnesium Sulfate | MAGNESIUM SULFATE HEPTAHYDRATE | Sagent Pharmaceuticals | a607796c-6676-4d0a-8108-8708fe6769ed | 2020-11-16 | Warnings, Adverse reactions | SK47B8698T |
| MAGNESIUM SULFATE | MAGNESIUM SULFATE HEPTAHYDRATE | Gland Pharma Limited | a9e706ac-9c5f-4b14-b277-53dee195ffc6 | 2020-07-14 | Warnings, Adverse reactions | SK47B8698T |
| TIS-U-SOL | SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE | Baxter Healthcare Corporation | 9da4121f-d62d-4da4-8dfb-0494da16015f | 2014-02-21 | SK47B8698T |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.